Omega Diagnostics Share Discussion Threads

[barrywhit] 24/2/2014 07:38

Hi Leeds,

They are showing quite a mark up at present, it will be interesting to see where we start share price wise today.......not a big free float of shares, could move very quickly.....

[leedslad001] 24/2/2014 07:21

Hi Barry
Yes more good news. Lot of people have forgotten about the new platform this on its own will be a good income stream.
As i said before next 2 years will be very exciting.

[barrywhit] 24/2/2014 07:12

Morning All,

Two very good RNS releases today, well done Omega.....

[dosser2] 20/2/2014 15:53

Just been tipped so will shoot up- for a while- on tips.com

[barrywhit] 20/2/2014 15:46

Afternoon All,

Very good support even at these levels.........

[barrywhit] 18/2/2014 16:41

Many Thanks Hyperboreus.........makes good reading, nothing we didn't know but shows good prospects for 2014...

[hyperboreus] 18/2/2014 16:02

Weakness in share today is understanable given the meteoric rise in the last few days but Edison Research have just issued their latest research note on Omega entitled Out of Alva, into Africa.



Anyone interested in reading it would have to register with them and be prepared to be bombarded with emails so be warned but the gist of it is that they are expecting an update on the automated allergy system iSYS soon with £0.5m sales FY 15.

They also seem to think that Visitec sales could develop strongly from Q3 2014 depending on how field trials go in Kenya & Mozambique next month, apparently Omega is planning to run claim-support studies to CE-mark the test.

They conclude that despite a recent significant advance in the share price the value of Omega looks too low.

[hyperboreus] 17/2/2014 17:02

Another very positive day and more importantly huge volume today by Omega's standards, interesting 39.5k buy late on, looking like Finncap's target price is about to be breached and still awaiting positive news on IDS-iSYS :}

[barrywhit] 17/2/2014 15:48

Hi Leeds,

Hello from cold wet Henley..........looking good....

[leedslad001] 17/2/2014 15:20

Hi from sunny Spain Onwards and upwards

[looby loo] 14/2/2014 22:17

A bit of press coverage:

[q1w2e3r4t5] 14/2/2014 21:42

"We will provide an update on CD4 before the end of the calendar year and a further update on the iSYS automation project in early 2014."

And then presumably notification of a sales order for the large-scale in country trials for CD-4...

Fantastic result, taking an assay from lab to large scale manufacture. Will put the company firmly on the radar or other labs seeking scale up and distribution.

[barrywhit] 14/2/2014 20:15

From the link above:

Visitect CD4 (Burnet Institute and Omega Diagnostics Ltd.)
Burnet Institute (Burnet) recently licensed its semi-quantitative CD4 technology to Omega Diagnostics Ltd. (UK). The test, which is now called the Visitect CD4, is expected to be available for commercial release in December 2012. At release, the cost of the test is expected to be about $5.00. The optional reader for the test, which has been developed by Axxin Ltd. (Australia), is expected to cost about $3,000, but may decline to below $2,000 over time. In addition to reading the results of the test, the reader also provides data storage and connectivity options, as well as real-time operating instructions for the tests.
In response to WHO recommendations for treatment initiation, Burnet re-optimized the Visitect CD4 to change the primary reference cut-off from 200 CD4+ T-cells/µL (the original design level) to 350 CD4+ T-cells/µL. Evaluation of the prototype version of the test at the 350 CD4/µL cutoff at the Burnet and Alfred Hospital, Melbourne, has shown 97% sensitivity for samples below 350 CD4/µL and 80% specificity for samples above 350 CD4/µL (total n=126). Clinical validation trials of the test are planned to follow in the UK, the United States, Kenya and South Africa in the last quarter of 2012.

[q1w2e3r4t5] 14/2/2014 12:51

hxxp://xa.yimg.com/kq/groups/9727221/1118639425/name/UNITAID_2012_Semi-annual_Update_HIV_Diagnostics_Technology_Landscape.pdf

Stacks up well; particularly at the 'remote rural' (mass) end of the market.

[leedslad001] 13/2/2014 18:36

Good news today all, sit back and enjoy the ride

[hyperboreus] 13/2/2014 12:09

I have no intention of selling any of my holding in Omega Dibs61, I am not a trader and prefer to invest and sit tight for the long haul.

I initially invested in Omega (before CD4 came to prominence) as I am a big fan of David Evans who has a fantastic track record in delivering value to shareholders. I had already bought my first tranch in Omega in March 2012 and then I noticed this:



That encouraged me to add more in April 2012 and although I haven't added since,mainly because I don't like to be too overweight with any holding I still think there is massive potential here.

I think Finncap's target price is about right at the moment, however given further positive developments the share price in say 12 or 18 months time should be considerably higher.

All the best Hyperboreus :)

[barrywhit] 13/2/2014 11:30

LW425,

With CE Mark probably double bag, with FDA approval Multi-Bag......imo

[lw425] 13/2/2014 10:55

if the hiv test kit makes it to the ce mark has anyone got any ideas for the share price. double or multi bagger from here. opinion please

[dibs61] 13/2/2014 10:53

No worries Hyperboreus. :) Well done on your investment. Are you planning on holding your full amount? I've bagged over 40% in just 3 months so also not complaining.

[hyperboreus] 13/2/2014 10:05

No you misunderstand the contents of my post Dibs61, it is fantastic news for Omega as I stated earlier this morning however 'no sense' comment was specifically due to the fact that Omega couldn't possibly issue a RNS in respect of the grant because it wasn't awarded to them.

I have been invested in Omega since March/April 2012 when the share price was at an all-time low and I am about to have a double-bagger here so I am in no mood to argue the toss so why don't we leave it at that?

[dibs61] 13/2/2014 09:31

Hyperboreus - you are correct of course to say they are not direct recipients. I didn't say they were! But I would not say it makes no sense? Of course it does. Whether they are direct or 'indirect' recipients of the grant is somewhat irrelevant because it is financial assistance toward the development of one of THEIR key products. Burnet is not making it! And of course you then contradict yourself completely by then agreeing with me that the announcement IS significant! So what was all that about exactly?

[dibs61] 13/2/2014 08:23

barrywhit - yep just the way I like it..... Until I've loaded up that is...

[barrywhit] 13/2/2014 08:12

This share really is under the radar with Investors...